Metformin Sensitizes Non-small Cell Lung Cancer Cells to an Epigallocatechin-3-Gallate (EGCG) Treatment by Suppressing the Nrf2/HO-1 Signaling Pathway
2017 ◽
Vol 13
(12)
◽
pp. 1560-1569
◽
Keyword(s):
Keyword(s):
2017 ◽
Keyword(s):
2015 ◽
Vol 91
(1)
◽
pp. 73-81
◽
Keyword(s):
Keyword(s):
Keyword(s):
2011 ◽
2020 ◽